322 related articles for article (PubMed ID: 27004714)
1. New depression diagnosis following prescription of codeine, hydrocodone or oxycodone.
Scherrer JF; Salas J; Bucholz KK; Schneider FD; Burroughs T; Copeland LA; Sullivan MD; Lustman PJ
Pharmacoepidemiol Drug Saf; 2016 May; 25(5):560-8. PubMed ID: 27004714
[TBL] [Abstract][Full Text] [Related]
2. Long-term use of hydrocodone vs. oxycodone in primary care.
Harris RA; Kranzler HR; Chang KM; Doubeni CA; Gross R
Drug Alcohol Depend; 2019 Dec; 205():107524. PubMed ID: 31707268
[TBL] [Abstract][Full Text] [Related]
3. Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose.
Snyder DL; Crowell MD; Horsley-Silva J; Ravi K; Lacy BE; Vela MF
Am J Gastroenterol; 2019 Sep; 114(9):1464-1469. PubMed ID: 31403963
[TBL] [Abstract][Full Text] [Related]
4. Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations.
Scherrer JF; Salas J; Copeland LA; Stock EM; Ahmedani BK; Sullivan MD; Burroughs T; Schneider FD; Bucholz KK; Lustman PJ
Ann Fam Med; 2016; 14(1):54-62. PubMed ID: 26755784
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products.
Bernhardt MB; Taylor RS; Hagan JL; Patel N; Chumpitazi CE; Fox KA; Glover C
Am J Health Syst Pharm; 2017 Dec; 74(24):2046-2053. PubMed ID: 29222361
[TBL] [Abstract][Full Text] [Related]
6. The influence of prescription opioid use duration and dose on development of treatment resistant depression.
Scherrer JF; Salas J; Sullivan MD; Schneider FD; Bucholz KK; Burroughs T; Copeland L; Ahmedani B; Lustman PJ
Prev Med; 2016 Oct; 91():110-116. PubMed ID: 27497660
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines.
Scherrer JF; Tucker J; Salas J; Zhang Z; Grucza R
JAMA Netw Open; 2020 Dec; 3(12):e2027481. PubMed ID: 33263762
[TBL] [Abstract][Full Text] [Related]
9. Likelihood of depressive symptoms in US older adults by prescribed opioid potency: National Health and Nutrition Examination Survey 2005-2013.
Brooks JM; Petersen C; Kelly SM; Reid MC
Int J Geriatr Psychiatry; 2019 Oct; 34(10):1481-1489. PubMed ID: 31134673
[TBL] [Abstract][Full Text] [Related]
10. Increased Risk of Depression Recurrence After Initiation of Prescription Opioids in Noncancer Pain Patients.
Scherrer JF; Salas J; Copeland LA; Stock EM; Schneider FD; Sullivan M; Bucholz KK; Burroughs T; Lustman PJ
J Pain; 2016 Apr; 17(4):473-82. PubMed ID: 26884282
[TBL] [Abstract][Full Text] [Related]
11. Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain.
Palangio M; Damask MJ; Morris E; Doyle RT; Jiang JG; Landau CJ; de Padova A
Clin Ther; 2000 Jul; 22(7):879-92. PubMed ID: 10945514
[TBL] [Abstract][Full Text] [Related]
12. Provider specialty and odds of a new codeine, hydrocodone, oxycodone and tramadol prescription before and after the CDC opioid prescribing guideline publication.
Tucker J; Salas J; Zhang Z; Grucza R; Scherrer JF
Prev Med; 2021 May; 146():106466. PubMed ID: 33636196
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain.
Naliboff BD; Wu SM; Schieffer B; Bolus R; Pham Q; Baria A; Aragaki D; Van Vort W; Davis F; Shekelle P
J Pain; 2011 Feb; 12(2):288-96. PubMed ID: 21111684
[TBL] [Abstract][Full Text] [Related]
14. Prescription of opioid analgesics for nontraumatic dental conditions in emergency departments.
Okunseri C; Dionne RA; Gordon SM; Okunseri E; Szabo A
Drug Alcohol Depend; 2015 Nov; 156():261-266. PubMed ID: 26471416
[TBL] [Abstract][Full Text] [Related]
15. Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies.
Stoops WW; Hatton KW; Lofwall MR; Nuzzo PA; Walsh SL
Psychopharmacology (Berl); 2010 Oct; 212(2):193-203. PubMed ID: 20665209
[TBL] [Abstract][Full Text] [Related]
16. Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products.
Zacny JP; Gutierrez S
Pain Med; 2008; 9(4):433-43. PubMed ID: 18489634
[TBL] [Abstract][Full Text] [Related]
17. Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids.
Yan CH; Hubbard CC; Lee TA; Sharp LK; Evans CT; Calip GS; Rowan SA; McGregor JC; Gellad WF; Suda KJ
JDR Clin Trans Res; 2023 Oct; 8(4):402-412. PubMed ID: 35708454
[TBL] [Abstract][Full Text] [Related]
18. Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone.
Ben-Joseph R; Bell JA; Brixner D; Kansal A; Paramore C; Chitnis A; Holly P; S Burgoyne D
J Manag Care Spec Pharm; 2016 Apr; 22(4):358-66. PubMed ID: 27023689
[TBL] [Abstract][Full Text] [Related]
19. The comparative safety of opioids for nonmalignant pain in older adults.
Solomon DH; Rassen JA; Glynn RJ; Garneau K; Levin R; Lee J; Schneeweiss S
Arch Intern Med; 2010 Dec; 170(22):1979-86. PubMed ID: 21149754
[TBL] [Abstract][Full Text] [Related]
20. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
